Elizabeth Horn Prsic, MD

• Bonnie Gould Rothberg
• Cary Gross
• Dmitry Kozhevnikov
• Hari Deshpande
• Harlan Krumholz
• Henry S. Park
• Jennifer Kapo
• Jensa Morris
• Jill Lacy
• Kerin Adelson
• Kevin Billingsley
• Maureen Canavan
• Michael Cecchini
• Nathaniel Parker, DO
• Sajid A Khan
• Shi-Yi Wang
• Vinay Rao
• Wei Cheng

Medical Oncology; Quality of Health Care; Palliative Medicine

End-of-life Care; Health Care Quality, Efficiency

• Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the USKerekes D, Frey A, Prsic E, Tran T, Clune J, Sznol M, Kluger H, Forman H, Becher R, Olino K, Khan S. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. JAMA Oncology 2024, 10: 342-351. PMID: 38175659, PMCID: PMC10767643, DOI: 10.1001/jamaoncol.2023.6025.
• Oncology hospitalist impact on hospice utilizationPrsic E, Morris J, Adelson K, Parker N, Gombos E, Kottarathara M, Novosel M, Castillo L, Rothberg B. Oncology hospitalist impact on hospice utilization. Cancer 2023, 129: 3797-3804. PMID: 37706601, DOI: 10.1002/cncr.35008.
• Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysisChow R, Yin L, Baqri W, Huang R, Boldt G, Younus J, Lock M, Prsic E, Zimmermann C, Herrstedt J. Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysis. Supportive Care In Cancer 2023, 31: 505. PMID: 37535218, DOI: 10.1007/s00520-023-07978-y.
• Advance care planning and hospital outcomes in solid tumour oncology inpatientsQeska D, Chow R, Balboni T, Kapo J, Zimmermann C, Prsic E. Advance care planning and hospital outcomes in solid tumour oncology inpatients. BMJ Supportive & Palliative Care 2023, spcare-2023-004396. PMID: 37500567, DOI: 10.1136/spcare-2023-004396.
• Opioid use, gabapentinoid use, and pain-related emergency department visits for patients living with advanced cancer.Jairam V, Lindsay M, Soulos P, Gross C, Prsic E, Baum L, Park H. Opioid use, gabapentinoid use, and pain-related emergency department visits for patients living with advanced cancer. Journal Of Clinical Oncology 2023, 41: 12119-12119. DOI: 10.1200/jco.2023.41.16_suppl.12119.
• The impact of oncology hospitalist utilization on resident education.Bhatt S, Yao J, Gould Rothberg B, Morris J, Parker N, Adelson K, Prsic E. The impact of oncology hospitalist utilization on resident education. Journal Of Clinical Oncology 2023, 41: 11034-11034. DOI: 10.1200/jco.2023.41.16_suppl.11034.
• Trends in Utilization of ICU for Older Adults With Cancer at the End-of-LifeJain S, Long J, Rao V, Law A, Walkey A, Lindenauer P, Prsic E, Krumholz H, Gross C. Trends in Utilization of ICU for Older Adults With Cancer at the End-of-Life. 2023, a1398-a1398. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1398.
• Lung Cancer Supportive Care and Symptom ManagementYao J, Novosel M, Bellampalli S, Kapo J, Joseph J, Prsic E. Lung Cancer Supportive Care and Symptom Management. Hematology/Oncology Clinics Of North America 2023, 37: 609-622. PMID: 37024385, DOI: 10.1016/j.hoc.2023.02.011.
• Outcomes on an inpatient oncology service after the introduction of hospitalist comanagementMorris J, Rothberg B, Prsic E, Parker N, Weber U, Gombos E, Kottarathara M, Billingsley K, Adelson K. Outcomes on an inpatient oncology service after the introduction of hospitalist comanagement. Journal Of Hospital Medicine 2023, 18: 391-397. PMID: 36891947, DOI: 10.1002/jhm.13071.
• To Create or Not to Create: How to Establish a System-Wide Proportionate Palliative Sedation Guideline Through Comprehensive Interdisciplinary Collaboration (TH108A)Bui T, Tenenbaum L, Choi A, Gupta J, Prsic E. To Create or Not to Create: How to Establish a System-Wide Proportionate Palliative Sedation Guideline Through Comprehensive Interdisciplinary Collaboration (TH108A). Journal Of Pain And Symptom Management 2023, 65: e251. DOI: 10.1016/j.jpainsymman.2022.12.028.
• Oncology Hospitalists: Hospice Utilization on an Inpatient Medical Oncology Service (SA314D)Prsic E, Morris J, Adelson K, Castillo L, Parker N, Bhatt S, Rothberg B. Oncology Hospitalists: Hospice Utilization on an Inpatient Medical Oncology Service (SA314D). Journal Of Pain And Symptom Management 2023, 65: e305-e306. DOI: 10.1016/j.jpainsymman.2022.12.134.
• Association of palliative care and hospital outcomes among solid tumour oncology inpatientsIm J, Chow R, Novosel M, Xiang J, Strait M, Rao V, Kapo J, Zimmermann C, Prsic E. Association of palliative care and hospital outcomes among solid tumour oncology inpatients. BMJ Supportive & Palliative Care 2023, spcare-2023-004207. PMID: 36849221, DOI: 10.1136/spcare-2023-004207.
• End-of-life care trajectories among older adults with lung cancerDavidoff AJ, Canavan ME, Prsic E, Saphire M, Wang SY, Presley CJ. End-of-life care trajectories among older adults with lung cancer. Journal Of Geriatric Oncology 2022, 14: 101381. PMID: 36202695, PMCID: PMC9974538, DOI: 10.1016/j.jgo.2022.09.010.
• The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting.Riaz F, Zhu H, Cheng W, Brongiel S, Baldwin E, Kier M, Zaemes J, Hearn C, Abdelghany O, Parikh R, Reuss J, Prsic E, Doroshow D. The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting. Journal Of Clinical Oncology 2022, 40: 300-300. DOI: 10.1200/jco.2022.40.28_suppl.300.
• Oncology-hospitalist co-management: A model for efficient, high-quality care and education.Morris J, Prsic E, Parker N, Weber U, Gombos E, Kottarathara M, Rothberg B, Adelson K. Oncology-hospitalist co-management: A model for efficient, high-quality care and education. Journal Of Clinical Oncology 2022, 40: 1-1. DOI: 10.1200/jco.2022.40.28_suppl.001.
• Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysisChow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, Winquist E, Lock M, Lustberg M, Prsic E. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Supportive & Palliative Care 2022, 13: 27-34. PMID: 36194493, DOI: 10.1136/spcare-2022-003815.
• Association Between Postdischarge Medical Oncology Follow-Up Appointments and Downstream Health Care Use: A Single-Institution ExperienceXiang J, Chow R, Reynoso A, Carafeno T, Deshpande H, Strait M, Prsic E. Association Between Postdischarge Medical Oncology Follow-Up Appointments and Downstream Health Care Use: A Single-Institution Experience. JCO Oncology Practice 2022, 18: e1466-e1474. PMID: 35696632, DOI: 10.1200/op.21.00868.
• Medical Outcomes of Oncology Inpatients With and Without Chaplain Spiritual Care Visit: The Yale New Haven Hospital ExperienceChow R, Tenenbaum L, Balboni TA, Prsic EH. Medical Outcomes of Oncology Inpatients With and Without Chaplain Spiritual Care Visit: The Yale New Haven Hospital Experience. JCO Oncology Practice 2021, 18: e334-e338. PMID: 34846912, DOI: 10.1200/op.21.00600.
• Implementation of Inpatient Palliative Care Consultation Triggers and Its Impact on Healthcare Use in Patients with Relapsed/Refractory Acute Myeloid LeukemiaXiang J, Prsic E, Adelson K, Prebet T. Implementation of Inpatient Palliative Care Consultation Triggers and Its Impact on Healthcare Use in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Blood 2021, 138: 3018. DOI: 10.1182/blood-2021-149300.
• Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysisChow R, Navari RM, Terry B, DeAngelis C, Prsic EH. Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis. Supportive Care In Cancer 2021, 30: 1015-1018. PMID: 34613472, DOI: 10.1007/s00520-021-06606-x.
• Impact of an automatic palliative care consultation trigger on healthcare use in patients with relapsed/refractory acute myeloid leukemia.Xiang J, Prsic E, Adelson K, Ozyck R, Prebet T. Impact of an automatic palliative care consultation trigger on healthcare use in patients with relapsed/refractory acute myeloid leukemia. Journal Of Clinical Oncology 2021, 39: 224-224. DOI: 10.1200/jco.2020.39.28_suppl.224.
• Cancer-related fatigue—pharmacological interventions: systematic review and network meta-analysisChow R, Bruera E, Sanatani M, Chiu L, Prsic E, Boldt G, Lock M. Cancer-related fatigue—pharmacological interventions: systematic review and network meta-analysis. BMJ Supportive & Palliative Care 2021, 13: 274-280. PMID: 34593386, DOI: 10.1136/bmjspcare-2021-003244.
• Music therapy effectiveness by duration in patients with cancer: a meta-regressionChow R, Bergner R, Prsic E. Music therapy effectiveness by duration in patients with cancer: a meta-regression. BMJ Supportive & Palliative Care 2021, 13: 117-120. PMID: 36810298, DOI: 10.1136/bmjspcare-2021-003163.
• The value of triggered geriatrics and palliative care consults in hospital medicine during the COVID-19 responsePrsic EH, Ouellet JA, Lai JM. The value of triggered geriatrics and palliative care consults in hospital medicine during the COVID-19 response. Annals Of Palliative Medicine 2021, 0: 50-50. PMID: 33615802, DOI: 10.21037/apm-20-2297.
• End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysisDavidoff AJ, Canavan ME, Prsic E, Saphire M, Wang SY, Presley CJ. End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysis. Supportive Care In Cancer 2021, 29: 3921-3932. PMID: 33389087, DOI: 10.1007/s00520-020-05964-2.
• Serotonin Syndrome in Palliative Care #403Chow R, Kozhevnikov D, Prsic EH. Serotonin Syndrome in Palliative Care #403. Journal Of Palliative Medicine 2020, 23: 1678-1680. PMID: 33306009, DOI: 10.1089/jpm.2020.0492.
• End-of-life (EOL) trajectories among older adults dying with lung cancer (LC).Davidoff A, Canavan M, Wang S, Prsic E, Saphire M, Presley C. End-of-life (EOL) trajectories among older adults dying with lung cancer (LC). Journal Of Clinical Oncology 2020, 38: e24008-e24008. DOI: 10.1200/jco.2020.38.15_suppl.e24008.
• The association between initial chemotherapy treatment timing, intensity, and end-of-life (EOL) care trajectory among older adults with advanced stage lung cancer (aLC).Presley C, Shahzad H, Canavan M, Prsic E, Saphire M, Wang S, Davidoff A. The association between initial chemotherapy treatment timing, intensity, and end-of-life (EOL) care trajectory among older adults with advanced stage lung cancer (aLC). Journal Of Clinical Oncology 2020, 38: e24009-e24009. DOI: 10.1200/jco.2020.38.15_suppl.e24009.
• Timing and location of palliative care consultation in metastatic pancreatic cancer: A retrospective, single-center observational study.Patel T, Miccio J, Srikumar T, Prsic E, Adelson K, Kozhevnikov D, Patel K, Lacy J, Cecchini M. Timing and location of palliative care consultation in metastatic pancreatic cancer: A retrospective, single-center observational study. Journal Of Clinical Oncology 2020, 38: 770-770. DOI: 10.1200/jco.2020.38.4_suppl.770.
• Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung CancerSaphire ML, Prsic E, Canavan ME, Wang SJ, Presley CJ, Davidoff AJ. Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung Cancer. Journal Of Pain And Symptom Management 2019, 59: 767-777.e1. PMID: 31778783, PMCID: PMC7338983, DOI: 10.1016/j.jpainsymman.2019.11.015.
• Patterns of palliative symptom management (PSM) medication use at end-of-life (EoL) among Medicare beneficiaries with advanced lung cancer (advLC).Davidoff A, Prsic E, Saphire M, Canavan M, Wang S, McCorkle R, Presley C. Patterns of palliative symptom management (PSM) medication use at end-of-life (EoL) among Medicare beneficiaries with advanced lung cancer (advLC). Journal Of Clinical Oncology 2019, 37: 130-130. DOI: 10.1200/jco.2019.37.27_suppl.130.
• Why, when, and where do older people die?Prsic E, Teno J. Why, when, and where do older people die? 2017, 1185-1190. DOI: 10.1093/med/9780198701590.003.0154.
• Why, when, and where do older people die?Prsic E, Spear R, Teno J. Why, when, and where do older people die? 2017, 1185-1190. DOI: 10.1093/med/9780198701590.003.0154_update_001.
• Site of death, place of care, and burdensome transitions among patients with advanced solid tumor malignancies or leukemia between 2000 and 2010.Prsic E, Teno J, Gozalo P. Site of death, place of care, and burdensome transitions among patients with advanced solid tumor malignancies or leukemia between 2000 and 2010. Journal Of Clinical Oncology 2015, 33: 144-144. DOI: 10.1200/jco.2015.33.29_suppl.144.
• Outpatient palliative care encounters in stage IV lung cancer care: An institutional review.Rizk S, Prsic E, Rafelson W, Reagan J, Taber A. Outpatient palliative care encounters in stage IV lung cancer care: An institutional review. Journal Of Clinical Oncology 2015, 33: 128-128. DOI: 10.1200/jco.2015.33.29_suppl.128.
• Education level and characterization of informed consent for PSA testing among males ages 55 to 69.Prsic E, Mantripragada K, Gopalsamy S, Santos M. Education level and characterization of informed consent for PSA testing among males ages 55 to 69. Journal Of Clinical Oncology 2015, 33: e16063-e16063. DOI: 10.1200/jco.2015.33.15_suppl.e16063.